Principia Biopharma Revenue and Competitors

Location

$127.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Principia Biopharma's estimated annual revenue is currently $188M per year.(i)
  • Principia Biopharma received $15.3M in venture funding in August 2015.
  • Principia Biopharma's estimated revenue per employee is $10,444,444
  • Principia Biopharma's total funding is $127.8M.

Employee Data

  • Principia Biopharma has 18 Employees.(i)
  • Principia Biopharma grew their employee count by -44% last year.

Principia Biopharma's People

NameTitleEmail/Phone
1
VP and Head Analytical and Pharmaceutical DevelopmentReveal Email/Phone
2
Director Clinical Data ManagementReveal Email/Phone
3
Associate Director - Chemical DevelopmentReveal Email/Phone
4
Senior Director Regulatory AffairsReveal Email/Phone
5
Sr Director Clinical Pharmacology and DMPKReveal Email/Phone
6
Sr. Manager, Regulatory AffairsReveal Email/Phone
7
Senior Research Associate - In Vivo PharmacologyReveal Email/Phone
8
Senior ScientistReveal Email/Phone
9
Bioanalystical /DMPK SpecialistReveal Email/Phone
10
Associate clinical sciencistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Principia Biopharma?

Principia's goal is to build a world-class, integrated biopharmaceutical company focused on oncology and autoimmune disease. We have validated our approach in vivo for multiple targets in different therapeutic areas. Our first program progressed from concept to clinical candidate in 18 months.

keywords:Biotechnology,Healthcare,Marketing,Pharmaceuticals

$127.8M

Total Funding

18

Number of Employees

$188M

Revenue (est)

-44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Principia Biopharma News

2022-04-06 - Health Hires: CSafe Global, Alumis

... that Klein has experience on legal issues like compliance and intellectual property, having previously worked at Principia Biopharma.

2022-03-30 - Alumis Expands Industry-Leading Leadership Team With ...

Sara Klein previously served as head of legal at Principia Biopharma following the company's acquisition by Sanofi, and as senior vice...

2019-09-08 - Here's Why Principia Biopharma Inc. (PRNB) Dropped -1.1%

In its latest trading session, Principia Biopharma Inc. (PRNB) dropped by -1.1% – here is what that looked like (as of 2019-09-09): ...

2019-09-03 - Meeder Asset Management Inc. Acquires New Stake in ...

Meeder Asset Management Inc. bought a new stake in Principia Biopharma Inc (NASDAQ:PRNB) in the second quarter, according to its most ...

2019-09-03 - Principia Biopharma Appoints Shawn Tomasello to Its Board ...

SOUTH SAN FRANCISCO, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0M18-14%$301.3M
#2
$2.8M18-53%N/A
#3
$2.8M18-18%N/A
#4
$1.7M19-5%N/A
#5
$3.8M20-77%N/A

Principia Biopharma Funding

DateAmountRoundLead InvestorsReference
2012-10-30$12.5MAArticle
2014-04-23$50.0MBSofinnova VenturesArticle
2015-08-12$15.3MUndisclosedArticle